verge genomics
Verge is transforming drug discovery by leveraging artificial intelligence and human data, aiming to reduce clinical failure rates and accelerate the development of new drugs. The company has built extensive datasets and collaborations with major pharmaceutical partners.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2015
Verge Genomics is a biotechnology company that has pioneered an all-in-human AI-powered drug discovery platform. Their platform integrates AI with human biology and genomic data to identify drug targets and optimize candidates, enabling faster and more efficient development. The company’s mission is to develop better drugs, faster, using technology, and to advance therapies through human-data–driven insights. Verge Genomics aims to transform traditional drug discovery by delivering actionable, human-relevant insights that accelerate medicines from discovery to the clinic.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for verge genomics.
27% below the average for this role